🎁 Our February Issue is online🎁 📘“In the Limelight” issue focusing on Structural Bioinformatics. Don't miss the new Review Articles, as introduced by Guest Editors @cmslnsoares and Diana Lousa 🔓 #StructuralBioinformatics #StructurePrediction

⚠️ Have you explored how you may benefit from Wiley's transitional agreements when publishing with us? 🤝Your institution or funder may be able to help with covering open access fees 🔎 🙏Waivers and Discounts 👉 #OpenAccess #OA

📣Did you know our journal publishes Research protocols? 🥼🗒️Research protocols describe a method in more detail than a standard methods section, with hints and tips on how to effectively perform the protocol Check out some examples 👉

📌 Pin to your calendars! 📚 Theory and concepts in biology📚 ⏳Don't miss these deadlines Abstracts Feb 11 ✏️ Register On-site Mar 25 Virtual Apr 29 🖱️ #EESTCBio #EcologyTwitter

This #WorldCancerDay, FEBS Open Bio contributes to the fight against cancer🎗️ We present the latest and ongoing research trends in the field of cancer biology🔬 Explore our Cancer section here📚 : #UnitedbyUnique #CancerResearch

RT @IvanaNovakNakir: Our newest paper - detailed protocol how to use flow cytometry to study selective autophagy using fluorescently-tagged…

RT @FEBSnews: The deadline for bursaries to the 49th FEBS Congress (5–9 July, Istanbul, Türkiye) is 13 March. Please share. On this FEBS Ne…

🌟Why publish in FEBS Open Bio? 📑We are a not-for-profit, open access journal owned by FEBS, a charitable organisation that promotes research & education in #LifeSciences Find out the journal's scope 🎯 #Biochemistry #SciTwitter #AcademicTwitter

🚨 The Milan Declaration on the Crucial Role of Science in meeting Global Challenges aims to enhance science as a cornerstone of global collaboration and strengthen civil society's engagement & trust in science @iubmb @pabmb_official ✍️ Sign here

🎉 We look forward to an exciting 2025! Here we reflect on the highlights & milestones achieved in 2024 as a journal and share our new plans for the year ahead! 👥 Check out how you could be involved 🗣️ #OpenAccess #SciComm #ECRchat #AcademicTwitter

Happy #ChineseNewYear🎉 Wishing all of our readers, authors, reviewers and editors a prosperous and joyful Year of the Snake🐍 ✨ Did you know FEBS Open Bio's Chinese Zodiac is the Rabbit?🐇 Comment yours below👇 #YearOfTheSnake #AcademicTwitter #SciTwitter

Expression and purification of E140 protein antigen fragments of Plasmodium vivax and Plasmodium berghei for serological assays 👉 🥼@pardi_lab @LipinszkiLab @SysbioS #Plasmodiumvivax #MalariaVaccines #VaccineDevelopment

Evaluation of synaptotagmin-1 action models by all-atom molecular dynamics simulations 👉 🥼@kjaczi @JoseRizoRey1 @CRosenmund #Synaptotagmin #MolecularDynamics #MembraneFusion

🚨Are you going? 🌱🪰🦠Wild frontiers of model organisms🪱🐭🐟 ⏳Don't miss these deadlines Abstracts Jan 28 ✏️ Register On-site Feb 25 Virtual Mar 31 🖱️ #ModelOrganisms #EESWildModels

🚨 The Milan Declaration on the Crucial Role of Science in meeting Global Challenges aims to foster and enhance science as a cornerstone of global collaboration and strengthen civil society's engagement and trust in science. ✍️ You may sign here

🚨 Hurry up and register ⭐ The expanding world of RBPs: from posttranscriptional control to riboregulation⭐ ⏳ Registration On-site 28 Jan Virtual 3 Mar 🖱️ #RBPs #RNAbindingproteins #RNAbinding

Purification and characterization of a thermophilic NAD+-dependent lactate dehydrogenase from Moorella thermoacetica ➡️ #LactateDehydrogenase #MoorellaThermoacetica

🏅 Congrats to Micaela Janet Sosa @UNCUYO, winner of a FEBS Open Bio Poster Prize at the “LII Annual Meeting of the Argentinian Biophysical Society”🇦🇷, with her work "Probing the Voltage Sensitivity of a Near-Infrared Dye in Polarized Lipid Membranes: A Computational Study"👏

🤝 Strengthening the bond with the scientific community: FEBS Open Bio in 2025 In this editorial, we reflect on a year of achievements, and look forward to the new developments planned for 2025 🖋️ #OpenAccess #SciTwitter #BioTwitter #Biochemistry

CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb ▶️ #PDAC #S1PR1 #HER3